Recombinant BCG expressing the LTAK63 adjuvant improves a short-term chemotherapy schedule in the control of tuberculosis in mice

Tuberculosis (TB) is one of the deadliest infectious diseases around the world. Prevention is based on the prophylactic use of BCG vaccine, effective in infants but as protection wanes with time, adults are less protected. Additionally, chemotherapy requires the use of many antibiotics for several m...

Descripción completa

Detalles Bibliográficos
Autores principales: Trentini, Monalisa Martins, Kanno, Alex Issamu, Rodriguez, Dunia, Marques-Neto, Lazaro Moreira, Eto, Silas Fernandes, Chudzinki-Tavassi, Ana Marisa, Leite, Luciana Cezar de Cerqueira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9471321/
https://www.ncbi.nlm.nih.gov/pubmed/36119106
http://dx.doi.org/10.3389/fimmu.2022.943558

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9471321/
https://www.ncbi.nlm.nih.gov/pubmed/36119106
http://dx.doi.org/10.3389/fimmu.2022.943558

Ejemplares similares